ATE234089T1 - Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen - Google Patents

Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Info

Publication number
ATE234089T1
ATE234089T1 AT99921939T AT99921939T ATE234089T1 AT E234089 T1 ATE234089 T1 AT E234089T1 AT 99921939 T AT99921939 T AT 99921939T AT 99921939 T AT99921939 T AT 99921939T AT E234089 T1 ATE234089 T1 AT E234089T1
Authority
AT
Austria
Prior art keywords
sclareolides
treatment
disorders
preparations containing
microbial infections
Prior art date
Application number
AT99921939T
Other languages
English (en)
Inventor
Ven Subbiah
Original Assignee
Reynolds Tobacco Co R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reynolds Tobacco Co R filed Critical Reynolds Tobacco Co R
Application granted granted Critical
Publication of ATE234089T1 publication Critical patent/ATE234089T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99921939T 1998-06-09 1999-05-12 Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen ATE234089T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/094,058 US6150381A (en) 1998-06-09 1998-06-09 Methods of treating microbial infection and therapeutic formulations therefor
PCT/US1999/010534 WO1999063978A2 (en) 1998-06-09 1999-05-12 Methods of treating microbial infection and therapeutic formulations therefor

Publications (1)

Publication Number Publication Date
ATE234089T1 true ATE234089T1 (de) 2003-03-15

Family

ID=22242608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921939T ATE234089T1 (de) 1998-06-09 1999-05-12 Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen

Country Status (6)

Country Link
US (2) US6150381A (de)
EP (1) EP1083895B1 (de)
AT (1) ATE234089T1 (de)
AU (1) AU3902299A (de)
DE (1) DE69905878T2 (de)
WO (1) WO1999063978A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150381A (en) * 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
DE19853476A1 (de) 1998-11-19 2000-05-31 Bionorica Arzneimittel Gmbh Prolaktin-senkendes Mittel
DE60014180T2 (de) * 2000-04-04 2005-10-06 Color Access, Inc. Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
DE10048596A1 (de) * 2000-09-30 2002-04-25 Henkel Kgaa Entzündungshemmende Wirkstoffe
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US20030072777A1 (en) * 2001-10-05 2003-04-17 Maes Daniel H. Combinatorial anti-acne compositions
US20040018220A1 (en) * 2002-07-26 2004-01-29 Chiou Consulting, Inc. Aqueous compositions for facial cosmetics
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1946368B (zh) * 2004-04-30 2012-05-09 花王株式会社 皱纹改善剂及皮肤化妆品
US7588759B2 (en) 2004-12-17 2009-09-15 Avoca, Inc. Compositions comprising sclareol or derivatives thereof and uses thereof
EP2014276A1 (de) * 2007-06-20 2009-01-14 Cognis IP Management GmbH Kosmetische Zusammensetzungen mit Sclareolid- und Hesperidin-Methyl-Chalcon
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
EP2789369B1 (de) 2013-04-14 2018-06-06 Symrise AG Eine Zubereitung zur Aufhellung von Haut und Haaren
EP3097905B1 (de) 2015-05-28 2020-11-04 Symrise AG Kosmetische zubereitungen
BR112018074709B1 (pt) 2016-05-30 2022-01-18 Symrise Ag Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido
BR112018076198A2 (pt) 2016-06-30 2019-03-26 Symrise Ag medicamento e composição cosmética compreendendo derivados do resorcinol
JP2019533009A (ja) * 2016-09-14 2019-11-14 グレイス・ブリーディング・リミテッド 非病原性の細菌を含む組成物並びに真菌性、細菌性及びウィルス性疾患から植物及び動物宿主を保護する方法
CN112236148A (zh) * 2018-05-28 2021-01-15 株式会社Lg生活健康 口腔疾病预防或治疗用组合物
CN112006970B (zh) * 2020-08-14 2021-10-22 珀莱雅化妆品股份有限公司 一种抗瘙痒功效组合物及其制备方法与应用
WO2023167867A1 (en) 2022-03-01 2023-09-07 Isp Investments Llc Sclareol or sclareolide for improving scalp conditions and hair growth

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060172A (en) 1959-04-29 1962-10-23 Reynolds Tobacco Co R Process for recovering sclareol from clary sage
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4130667A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
GB2068228B (en) 1980-01-24 1984-02-29 Janssen Pharmaceutica Nv Anti-microbial compositions for the topical treatment of acne vulgaris
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP2700070B2 (ja) * 1988-06-10 1998-01-19 株式会社資生堂 グラム陽性嫌気性細菌用抗菌剤及びそれを用いた皮膚外用剤、口腔用組成物
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
JPH0779682B2 (ja) 1989-08-28 1995-08-30 インターナショナル フレーバーズ アンド フレーグランシィズ インコーポレーテッド 微生物の生物学的に純粋な培養物、ラクトン生成方法、ジオール生成方法、化合物生成方法および環状エーテルの生成方法
US5212078A (en) 1989-08-28 1993-05-18 International Flavors And Fragrances Inc. Process for producing a lactone
US5155029A (en) 1989-08-28 1992-10-13 International Flavors & Fragrances Inc. Process for producing a cyclic ether
US4970163A (en) 1989-08-28 1990-11-13 International Flavors & Fragrances Inc. Process for producing diol and lactone and microorganisms capable of same
DE3942358A1 (de) 1989-12-21 1991-06-27 Henkel Kgaa Verfahren zur herstellung von sclareolid
EP0636126B1 (de) 1992-04-16 1997-01-08 Henkel Kommanditgesellschaft auf Aktien Verfahren zur herstellung von sclareolid
US5358752A (en) * 1993-02-23 1994-10-25 Norac Technologies Inc. Skin care composition
GB9500024D0 (en) 1995-01-04 1995-03-01 Sod Conseils Rech Applic Treatment of excessive cell proliferation disorders
CA2178528C (en) * 1995-06-09 2000-07-18 Hidehiko Takahashi Therapeutics containing 5alpha - reductase inhibitors
JPH10298070A (ja) * 1997-04-22 1998-11-10 Toagosei Co Ltd 抗真菌剤
US6150381A (en) * 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor

Also Published As

Publication number Publication date
WO1999063978A3 (en) 2000-04-13
WO1999063978A2 (en) 1999-12-16
DE69905878T2 (de) 2003-12-04
US6331551B1 (en) 2001-12-18
US6150381A (en) 2000-11-21
DE69905878D1 (de) 2003-04-17
EP1083895A2 (de) 2001-03-21
EP1083895B1 (de) 2003-03-12
AU3902299A (en) 1999-12-30

Similar Documents

Publication Publication Date Title
ATE234089T1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
HK1091151A1 (en) Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
NO20025450D0 (no) Ny farmasöytisk sammensetning
NO961326D0 (no) Inhibitorer av
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
ES2074276T3 (es) Metodo de tratamiento de la alopecia.
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
TW200505473A (en) Compositions and methods for treatment of psoriasis
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
DK1232173T3 (da) Nye fusidinsyrederivater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties